Nicorandil for Injection 12mg – For Laboratory Research Use Only

Nicorandil for Injection 12mg – For Laboratory Research Use Only

$2.00

Nicorandil for Injection (Ruikexi) contains 12mg of nicorandil per vial, supplied as 4 vials per box. Manufactured by Beijing Sihuan Kebao Pharmaceutical. Approved under H20120069. For laboratory research use only.?For wholesale prices, other specifications and uses, please consult our staff?

EMI starting from $0.00/month - View Plans
Category:

Description

Nicorandil is a dual-action vasodilator that acts as both a potassium channel opener and nitrate donor. In research, it is widely utilized in cardiovascular pharmacology to simulate ischemic heart conditions and study myocardial protection and vasodilation mechanisms.

This product delivers 12mg nicorandil per vial, with 4 vials per box, manufactured by Beijing Sihuan Kebao Pharmaceutical Co., Ltd. under NMPA approval number H20120069. It is intended strictly for non-clinical laboratory use.


Product Specifications

ParameterDetails
Product NameNicorandil for Injection (Ruikexi)
Active IngredientNicorandil
CAS Number65141-46-0
Molecular FormulaC8H9N3O4
Molecular Weight211.18 g/mol
Dosage FormInjection (Powder for Reconstitution)
Strength12mg per vial
Packaging4 vials per box
Approval NumberH20120069 (China NMPA)
Product Code86900151000945
ManufacturerBeijing Sihuan Kebao Pharmaceutical Co., Ltd.
Barcode6940146004026
Intended UseLaboratory research only
Storage ConditionsStore in a cool, dry place below 25°C

Mechanism of Action & Research Applications

Nicorandil combines the properties of nitrate-like vasodilation and ATP-sensitive potassium channel activation. It causes relaxation of vascular smooth muscles, improves coronary blood flow, and reduces cardiac preload and afterload.

Research Applications:

  • Myocardial ischemia and reperfusion models

  • Vasodilation and endothelial response studies

  • Angina mechanism simulations

  • Comparative studies with nitrates and K-ATP openers

  • Evaluation of cardioprotective agents


Potential Side Effects in Research Models

  • Hypotension

  • Headache

  • Flushing

  • Gastrointestinal discomfort in high-dose models


Handling & Safety Information

Use Restriction: For laboratory research only.
Protective Equipment: Lab coat, gloves, and safety glasses recommended.
Storage: Keep below 25°C, away from moisture and light.
Disposal: Dispose of in accordance with institutional and environmental safety regulations.


Research Use Disclaimer

This product is provided strictly for laboratory research and is not intended for human or veterinary use. Misuse may result in regulatory or safety consequences. Handle only in certified research environments following proper protocols.

Additional information

Weight1 kg
Dimensions42 × 23 × 42 cm

Reviews

There are no reviews yet.

Be the first to review “Nicorandil for Injection 12mg – For Laboratory Research Use Only”

Your email address will not be published. Required fields are marked *

Q1: Is this product approved for clinical use?

A1: No, it is intended strictly for non-human laboratory research.

Q2: Can this be ordered in bulk?

A2: Yes, we support both wholesale and retail orders. Contact us for bulk pricing.

Q3: Is this the same formulation used for angina?

A3: It contains the same active compound, but this version is designated for research purposes only, not clinical use.

Q4: Are SDS and COA documents provided?

A4: Yes, Certificate of Analysis (COA) and Safety Data Sheet (SDS) are available upon request.

Q5: How is it administered in research studies?

A5: Typically used via intravenous injection following reconstitution, as per lab protocols.

Q6: What does “Ruikexi” refer to?

A6: “Ruikexi” is the commercial brand name used by the manufacturer, Beijing Sihuan Kebao.

Q7: What studies is nicorandil most commonly used in?

A7: It is widely used in myocardial ischemia models, vasodilation research, and cardiac drug interaction studies.

Q8: How stable is this compound?

A8: When stored properly, it maintains integrity under recommended conditions. Reconstituted solutions should be used promptly.

Q9: What is the NMPA approval number?

A9: The approval number is H20120069, issued by the China NMPA.

Q10: Can I combine this with other cardiovascular agents for interaction studies?

A10: Yes, it is often used in combination studies with beta-blockers, nitrates, or calcium channel blockers in non-clinical settings.


EMI Options